Novartis AG Rightofuse Assets
Novartis AG (NVSEF) had Rightofuse Assets of $1.57 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2026-02-04
- 2025-12-31: Rightofuse Assets $1.57B.
- 2025-06-30: Rightofuse Assets $1.45B.
- 2024-12-31: Rightofuse Assets $1.42B.
- 2024-06-30: Rightofuse Assets $1.37B.
| Period end | Rightofuse Assets | Rightofuse Assets as first filed |
|---|---|---|
| 2025-12-31 | $1.57B 20-F · filed 2026-02-04 | |
| 2025-06-30 | $1.45B 6-K · filed 2025-07-17 | |
| 2024-12-31 | $1.42B 20-F · filed 2026-02-04 | |
| 2024-06-30 | $1.37B 6-K · filed 2024-07-18 | |
| 2023-12-31 | $1.41B 20-F · filed 2026-02-04 | |
| 2023-06-30 | $1.45B 6-K · filed 2023-07-18 | |
| 2022-12-31 | $1.43B 20-F · filed 2025-01-31 | |
| 2022-06-30 | $1.47B 6-K · filed 2022-07-19 | |
| 2021-12-31 | $1.56B 20-F · filed 2024-01-31 | |
| 2021-06-30 | $1.61B 6-K · filed 2021-07-21 | |
| 2020-12-31 | $1.68B 20-F/A · filed 2023-05-15 | |
| 2020-06-30 | $1.64B 6-K · filed 2020-07-21 | |
| 2019-12-31 | $1.68B 20-F · filed 2022-02-02 | |
| 2019-06-30 | $1.76B 6-K · filed 2019-07-18 | |
| 2019-01-01 | $1.55B 20-F · filed 2022-02-02 | $1.55B 6-K · filed 2019-07-18 |